Capabilities · Semi-solids & specialised presentations

Creams & ointments

A proposed service scope for semi-solid topical presentations, connecting material mixing, homogenisation, bulk transfer and final tube or container filling.

PlannedCatalogue scope

Illustrative unbranded aluminium tube nozzle detail.
Illustrative unbranded aluminium tube nozzle detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Cream and ointment handling is presented as a planned service domain. The exact product, material characteristics, presentation format and technical route would ultimately define the applicable boundaries for any scope.

The initial Boten plan covers sterile injectable presentations and protein raw-material production. This semi-solid domain represents a proposed expansion for discussion, meaning the scope remains outside the initial plan and needs confirmation.

High-shear homogenisation and viscous product transfer represent distinct technical subjects. Inclusion within this catalogue does not establish that appropriate mechanical processing equipment would be specified for a particular formulation.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Oil-in-water creamsEmulsion formulations requiring specific thermal and mechanical processing steps.Catalogue scopePlanned
Non-aqueous ointmentsHydrophobic preparations requiring dedicated homogenisation and transfer assessments.Catalogue scopePlanned
Primary tube packagingPrimary packagingAluminium or polymer tube filling and sealing operations.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Raw material handling

Assess material properties, weighing conditions and appropriate dispensing environments for the required bulk ingredients.

02 · Process stage

Planned

Phase preparation and heating

Define necessary thermal requirements for separate phases prior to the combining stage.

03 · Process stage

Planned

Emulsification and homogenisation

Consider required shear forces and temperature controls necessary for correct phase integration.

04 · Process stage

Planned

Cooling and bulk transfer

Establish controlled cooling parameters and the method for moving viscous product into holding vessels.

05 · Process stage

Planned

Tube or container filling

Define the filling mechanism, weight controls and closure requirements for the final presentation.

06 · Process stage

Planned

Inspection and batch review

Connect bulk processing records and analytical results to the accountable disposition decision.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Primary packaging

Blisters, bottles, sachets, tubes and presentation-specific container systems.

Explore proposed scope

02PlannedCatalogue scope

Topical solutions & washes

Liquid topical presentations with product-specific controls.

Explore proposed scope

03PlannedCatalogue scope

Process development & scale-up

Process definition, scale considerations and the evidence needed for transfer.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product formulation details
Complete qualitative and quantitative composition with relevant physicochemical properties.
Facility and systems
Defined processing areas, qualified mixing vessels and approved thermal controls.
Process evidence
Established parameters for homogenisation and transfer stages under controlled conditions.
Quality responsibilities
Agreed accountability for component release, testing and final product review.
Regulatory context
Applicable permissions covering the intended manufacturing activity and product category.
Technical agreement
Formalised boundaries defining responsibilities and information exchange for any future work.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating semi-solid service.

Are topical formulations in the initial plan?

No. The initial plan identifies sterile injectable presentations and protein raw-material production. Creams and ointments are proposed catalogue additions requiring separate scope confirmation.

What information helps define the question?

Identify the product, container, development stage, destination and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, processing evidence and a technical agreement would need to be established before a service could exist.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma